Fig. 1. Schematic diagram of BC200 RNA.
Fig. 2. Involvement of BC200 RNA in the genesis and development of cancers.
Table 1. Summary of clinical studies of BC200 RNA in cancer
참고문헌
- Amin, V., Harris, R.A., Onuchic, V., Jackson, A.R., Charnecki, T., Paithankar, S., Lakshmi Subramanian, S., Riehle, K., Coarfa, C., and Milosavljevic, A. (2015). Epigenomic footprints across 111 reference epigenomes reveal tissue-specific epigenetic regulation of lincRNAs. Nat. Commun. 6, 6370. https://doi.org/10.1038/ncomms7370
- Baer, C., Claus, R., and Plass, C. (2013). Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 73, 473-477. https://doi.org/10.1158/0008-5472.CAN-12-3731
- Balas, M.M., and Johnson, A.M. (2018). Exploring the mechanisms behind long noncoding RNAs and cancer. Noncoding RNA Res. 3, 108-117. https://doi.org/10.1016/j.ncrna.2018.03.001
- Bandres, E., Agirre, X., Bitarte, N., Ramirez, N., Zarate, R., Roman-Gomez, J., Prosper, F., and Garcia-Foncillas, J. (2009). Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 125, 2737-2743. https://doi.org/10.1002/ijc.24638
- Barh, D., Malhotra, R., Ravi, B., and Sindhurani, P. (2010). MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr. Oncol. 17, 70-80.
- Beg, M.S., Brenner, A.J., Sachdev, J., Borad, M., Kang, Y.K., Stoudemire, J., Smith, S., Bader, A.G., Kim, S., and Hong, D.S. (2017). Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest. New Drugs 35, 180-188. https://doi.org/10.1007/s10637-016-0407-y
- Benjamin, H., Lebanony, D., Rosenwald, S., Cohen, L., Gibori, H., Barabash, N., Ashkenazi, K., Goren, E., Meiri, E., Morgenstern, S., et al. (2010). A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J. Mol. Diagn. 12, 771-779. https://doi.org/10.2353/jmoldx.2010.090169
- Booy, E.P., McRae, E.K., Koul, A., Lin, F., and McKenna, S.A. (2017). The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation. Mol. Cancer 16, 109. https://doi.org/10.1186/s12943-017-0679-7
- Brase, J.C., Johannes, M., Schlomm, T., Falth, M., Haese, A., Steuber, T., Beissbarth, T., Kuner, R., and Sultmann, H. (2011). Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer 128, 608-616. https://doi.org/10.1002/ijc.25376
- Briggs, J.A., Wolvetang, E.J., Mattick, J.S., Rinn, J.L., and Barry, G. (2015). Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution. Neuron 88, 861-877. https://doi.org/10.1016/j.neuron.2015.09.045
- Brosnan, C.A., and Voinnet, O. (2009). The long and the short of noncoding RNAs. Curr. Opin. Cell Biol. 21, 416-425. https://doi.org/10.1016/j.ceb.2009.04.001
- Bushati, N., and Cohen, S.M. (2007). microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205. https://doi.org/10.1146/annurev.cellbio.23.090506.123406
- Chen, W., Bocker, W., Brosius, J., and Tiedge, H. (1997). Expression of neural BC200 RNA in human tumours. J. Pathol. 183, 345-351. https://doi.org/10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8
- Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006. https://doi.org/10.1038/cr.2008.282
- Chen, X., Mangala, L.S., Rodriguez-Aguayo, C., Kong, X., Lopez-Berestein, G., and Sood, A.K. (2018). RNA interference-based therapy and its delivery systems. Cancer Metastasis Rev. 37, 107-124. https://doi.org/10.1007/s10555-017-9717-6
- Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., et al. (2011). Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 102, 245-252. https://doi.org/10.1111/j.1349-7006.2010.01737.x
- Consortium, E.P. (2004). The ENCODE (ENCyclopedia Of DNA Elements) Project. Sci. 306, 636-640. https://doi.org/10.1126/science.1105136
- Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D.G., et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789. https://doi.org/10.1101/gr.132159.111
- Duning, K., Buck, F., Barnekow, A., and Kremerskothen, J. (2008). SYNCRIP, a component of dendritically localized mRNPs, binds to the translation regulator BC200 RNA. J. Neurochem. 105, 351-359. https://doi.org/10.1111/j.1471-4159.2007.05138.x
- Ebisuya, M., Yamamoto, T., Nakajima, M., and Nishida, E. (2008). Ripples from neighbouring transcription. Nat. Cell Biol. 10, 1106-1113. https://doi.org/10.1038/ncb1771
- Eom, T., Berardi, V., Zhong, J., Risuleo, G., and Tiedge, H. (2011). Dual nature of translational control by regulatory BC RNAs. Mol. Cell. Biol. 31, 4538-4549. https://doi.org/10.1128/MCB.05885-11
- Gu, L., Lu, L., Zhou, D., and Liu, Z. (2018). Long noncoding RNA BCYRN1 promotes the proliferation of colorectal cancer cells via upregulating NPR3 expression. Cell. Physiol. Biochem. 48, 2337-2349. https://doi.org/10.1159/000492649
- Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., Tsai, M.C., Hung, T., Argani, P., Rinn, J.L., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076. https://doi.org/10.1038/nature08975
- Hajjari, M., and Salavaty, A. (2015). HOTAIR: an oncogenic long noncoding RNA in different cancers. Cancer Biol. Med. 12, 1-9.
- Hasanzadeh, M., Movahedi, M., Rejali, M., Maleki, F., Moetamani-Ahmadi, M., Seifi, S., Hosseini, Z., Khazaei, M., Amerizadeh, F., Ferns, G.A., et al. (2019). The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer. J. Cell Physiol. 234, 1289-1294. https://doi.org/10.1002/jcp.27160
- Hu, T., and Lu, Y.R. (2015). BCYRN1, a c-MYC-activated long noncoding RNA, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int. 15, 36. https://doi.org/10.1186/s12935-015-0183-3
- Iacoangeli, A., Adzovic, L., Chen, E.Q., Latif Cattie, R., Soff, G.A., and Tiedge, H. (2018). Regulatory BC200 RNA in peripheral blood of patients with invasive breast cancer. J. Investig. Med. 66, 1055-1063. https://doi.org/10.1136/jim-2018-000717
- Iacoangeli, A., Lin, Y., Morley, E.J., Muslimov, I.A., Bianchi, R., Reilly, J., Weedon, J., Diallo, R., Bocker, W., and Tiedge, H. (2004). BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 25, 2125-2133. https://doi.org/10.1093/carcin/bgh228
- Iorio, M.V., and Croce, C.M. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143-159. https://doi.org/10.1002/emmm.201100209
- Jain, S., Thakkar, N., Chhatai, J., Pal Bhadra, M., and Bhadra, U. (2017). Long non-coding RNA: Functional agent for disease traits. RNA Biol. 14, 522-535. https://doi.org/10.1080/15476286.2016.1172756
- Jang, S., Shin, H., Lee, J., Kim, Y., Bak, G., and Lee, Y. (2017). Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2. FEBS Lett. 591, 393-405. https://doi.org/10.1002/1873-3468.12544
- Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D., and Slack, F.J. (2005). RAS is regulated by the let-7 microRNA family. Cell 120, 635-647. https://doi.org/10.1016/j.cell.2005.01.014
- Johnsson, P., and Morris, K.V. (2014). Expanding the functional role of long noncoding RNAs. Cell Res. 24, 1284-1285. https://doi.org/10.1038/cr.2014.104
- Kim, Y., Lee, J., Shin, H., Jang, S., Kim, S.C., and Lee, Y. (2017). Biosynthesis of brain cytoplasmic 200 RNA. Sci. Rep. 7, 6884. https://doi.org/10.1038/s41598-017-05097-3
- Ko, J.Y., Oh, S., and Yoo, K.H. (2017). Functional enhancers as master regulators of tissue-specific gene regulation and cancer Development. Mol. Cells 40, 169-177.
- Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., et al. (2011). Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320-6326. https://doi.org/10.1158/0008-5472.CAN-11-1021
- Kondrashov, A.V., Kiefmann, M., Ebnet, K., Khanam, T., Muddashetty, R.S., and Brosius, J. (2005). Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP). J. Mol. Biol. 353, 88-103. https://doi.org/10.1016/j.jmb.2005.07.049
- Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. https://doi.org/10.1038/35057062
- Lee, Y.S., and Dutta, A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025-1030. https://doi.org/10.1101/gad.1540407
- Li, P., Yang, B., Xia, S., Chen, L.-h., Ning, N., Ma, B., Liu, Q., Yang, H., Zhang, D.S.-z., and Du, X.N. (2016). BC200 RNA is over-expressed in colorectal cancer and promotes migration and invasion of HCT116 cells. Int. J. Clin. Exp. Patho. 9, 1481-1486.
- Lin, D., Pestova, T.V., Hellen, C.U., and Tiedge, H. (2008). Translational control by a small RNA: dendritic BC1 RNA targets the eukaryotic initiation factor 4A helicase mechanism. Mol. Cell. Biol. 28, 3008-3019. https://doi.org/10.1128/MCB.01800-07
- Long, L., Huang, G., Zhu, H., Guo, Y., Liu, Y., and Huo, J. (2013). Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J. Transl. Med. 11, 275. https://doi.org/10.1186/1479-5876-11-275
- Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. https://doi.org/10.1038/nature03702
- Luo, P., Liu, X.F., Wang, Y.C., Li, N.D., Liao, S.J., Yu, M.X., Liang, C.Z., and Tu, J.C. (2017). Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis. Oncotarget 8, 23927-23936.
- Ma, J., Zhang, J., Weng, Y.C., and Wang, J.C. (2018). EZH2-Mediated microRNA-139-5p regulates epithelial-mesenchymal transition and lymph node metastasis of pancreatic cancer. Mol. Cells 41, 868-880.
- Mitomo, S., Maesawa, C., Ogasawara, S., Iwaya, T., Shibazaki, M., Yashima-Abo, A., Kotani, K., Oikawa, H., Sakurai, E., Izutsu, N., et al. (2008). Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci. 99, 280-286. https://doi.org/10.1111/j.1349-7006.2007.00666.x
- Muddashetty, R., Khanam, T., Kondrashov, A., Bundman, M., Iacoangeli, A., Kremerskothen, J., Duning, K., Barnekow, A., Huttenhofer, A., Tiedge, H., et al. (2002). Poly(A)-binding protein is associated with neuronal BC1 and BC200 ribonucleoprotein particles. J. Mol. Biol. 321, 433-445. https://doi.org/10.1016/S0022-2836(02)00655-1
- Pasmant, E., Sabbagh, A., Vidaud, M., and Bieche, I. (2011). ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448. https://doi.org/10.1096/fj.10-172452
- Peng, J., Hou, F., Feng, J., Xu, S.X., and Meng, X.Y. (2018). Long non-coding RNA BCYRN1 promotes the proliferation and metastasis of cervical cancer via targeting microRNA-138 in vitro and in vivo. Oncol. Lett. 15, 5809-5818.
- Qu, H., Xu, W., Huang, Y., and Yang, S. (2011). Circulating miRNAs: promising biomarkers of human cancer. Asian Pacific Journal of cancer prevention: APJCP 12, 1117-1125.
- Qureshi, I.A., and Mehler, M.F. (2012). Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nature reviews. Neuroscience 13, 528-541. https://doi.org/10.1038/nrn3234
- Ren, H., Yang, X., Yang, Y., Zhang, X., Zhao, R., Wei, R., Zhang, X., and Zhang, Y. (2018). Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma. Oncotarget 9, 4851-4861.
- Richter, J.D., and Klann, E. (2009). Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev. 23, 1-11. https://doi.org/10.1101/gad.1735809
- Samson, J., Cronin, S., and Dean, K. (2018). BC200 (BCYRN1) - The shortest, long, non-coding RNA associated with cancer. Noncoding RNA Res. 3, 131-143. https://doi.org/10.1016/j.ncrna.2018.05.003
- Schramm, L., and Hernandez, N. (2002). Recruitment of RNA polymerase III to its target promoters. Genes Dev. 16, 2593-2620. https://doi.org/10.1101/gad.1018902
- Shin, H., Lee, J., Kim, Y., Jang, S., Lee, Y., Kim, S., and Lee, Y. (2017). Knockdown of BC200 RNA expression reduces cell migration and invasion by destabilizing mRNA for calcium-binding protein S100A11. RNA Biol. 14, 1418-1430. https://doi.org/10.1080/15476286.2017.1297913
- Singh, R., Gupta, S.C., Peng, W.X., Zhou, N., Pochampally, R., Atfi, A., Watabe, K., Lu, Z., and Mo, Y.Y. (2016). Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death Dis. 7, e2262. https://doi.org/10.1038/cddis.2016.168
- Smalheiser, N.R. (2014). The RNA-centred view of the synapse: noncoding RNAs and synaptic plasticity. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369.
- Song, W., and Zou, S.B. (2016). Prognostic role of lncRNA HOTAIR in esophageal squamous cell carcinoma. Clin. Chim. Acta. 463, 169-173. https://doi.org/10.1016/j.cca.2016.10.035
- Spector, Y., Fridman, E., Rosenwald, S., Zilber, S., Huang, Y., Barshack, I., Zion, O., Mitchell, H., Sanden, M., and Meiri, E. (2013). Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas. Mol. Oncol. 7, 732-738. https://doi.org/10.1016/j.molonc.2013.03.002
- Struhl, K. (2007). Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat. Struct. Mol. Biol. 14, 103-105. https://doi.org/10.1038/nsmb0207-103
- Sutcliffe, J.G., Milner, R.J., Bloom, F.E., and Lerner, R.A. (1982). Common 82-nucleotide sequence unique to brain RNA. Proc. Natl. Acad. Sci. USA 79, 4942-4946. https://doi.org/10.1073/pnas.79.16.4942
- Sutcliffe, J.G., Milner, R.J., Gottesfeld, J.M., and Lerner, R.A. (1984). Identifier sequences are transcribed specifically in brain. Nature 308, 237-241. https://doi.org/10.1038/308237a0
- Tiedge, H., Chen, W., and Brosius, J. (1993). Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J. Neurosci. 13, 2382-2390. https://doi.org/10.1523/JNEUROSCI.13-06-02382.1993
- Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261. https://doi.org/10.1073/pnas.0510565103
- Wapinski, O., and Chang, H.Y. (2011). Long noncoding RNAs and human disease. Trends Cell Biol. 21, 354-361. https://doi.org/10.1016/j.tcb.2011.04.001
- Ward, L.D., and Kellis, M. (2012). Interpreting noncoding genetic variation in complex traits and human disease. Nat. Biotechnol. 30, 1095-1106. https://doi.org/10.1038/nbt.2422
- Watson, J.B., and Sutcliffe, J.G. (1987). Primate brain-specific cytoplasmic transcript of the Alu repeat family. Mol. Cell. Biol. 7, 3324-3327. https://doi.org/10.1128/MCB.7.9.3324
- Wilusz, J.E., Sunwoo, H., and Spector, D.L. (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 23, 1494-1504. https://doi.org/10.1101/gad.1800909
- Wu, D.I., Wang, T., Ren, C., Liu, L., Kong, D., Jin, X., Li, X., and Zhang, G. (2016). Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin. Oncol. Lett. 11, 1189-1194. https://doi.org/10.3892/ol.2015.3983
- Wu, K., Xu, K., Liu, K., Huang, J., Chen, J., Zhang, J., and Zhang, N. (2018). Long noncoding RNA BC200 regulates cell growth and invasion in colon cancer. Int. J. Biochem. Cell Biol. 99, 219-225. https://doi.org/10.1016/j.biocel.2018.04.001
- Wu, Z., Liu, X., Liu, L., Deng, H., Zhang, J., Xu, Q., Cen, B., and Ji, A. (2014). Regulation of lncRNA expression. Cell Mol. Biol. Lett. 19, 561-575.
- Zhang, H., Zhang, H., Zhao, M., Lv, Z., Zhang, X., Qin, X., Wang, H., Wang, S., Su, J., Lv, X., et al. (2013). MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol. Biochem. 31, 56-65. https://doi.org/10.1159/000343349
- Zhang, Y., Wang, L.J., Li, W.F., Zhang, X., and Yang, X.J. (2018). The prognostic value of HOTAIR for predicting long-term prognosis of patients with gastrointestinal cancers. Medicine (Baltimore) 97, e11139. https://doi.org/10.1097/MD.0000000000011139
- Zhao, R.H., Zhu, C.H., Li, X.K., Cao, W., Zong, H., Cao, X.G., and Hu, H.Y. (2016). BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients. Onco. Targets Ther. 9, 2221-2226.
피인용 문헌
- Non-Coding RNAs in Caenorhabditis elegans Aging vol.42, pp.5, 2019, https://doi.org/10.14348/molcells.2019.0077
- Heterogeneous Sequences of Brain Cytoplasmic 200 RNA Formed by Multiple Adenine Nucleotide Insertions vol.42, pp.6, 2018, https://doi.org/10.14348/molcells.2019.0108
- BCYRN1 is correlated with progression and prognosis in gastric cancer vol.39, pp.11, 2018, https://doi.org/10.1042/bsr20190505
- Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.598817
- Brain Cytoplasmic RNAs in Neurons: From Biosynthesis to Function vol.10, pp.2, 2018, https://doi.org/10.3390/biom10020313
- RNA polymerase III transcription as a disease factor vol.34, pp.13, 2018, https://doi.org/10.1101/gad.333989.119
- Clues of in vivo nuclear gene regulation by mitochondrial short non-coding RNAs vol.10, pp.None, 2018, https://doi.org/10.1038/s41598-020-65084-z
- The Oncosuppressors MEN1 and CDC73 Are Involved in LNCRNA Deregulation in Human Parathyroid Tumors vol.35, pp.12, 2020, https://doi.org/10.1002/jbmr.4154